How the public sector is working with private firms to fight COVID-19

How the public sector is working with private firms to fight COVID-19
Shortly after the World Health Organization learned of “a pneumonia of unknown cause … in Wuhan, China,” leading U.S. research firms started working around the clock to learn more about the novel coronavirus. In just three months, dozens of promising treatments and vaccines have entered the pipeline. Some are already in human trials.

This record-breaking pace is thanks, in part, to the dedicated efforts of America’s biopharmaceutical industry. Every day, our nation’s scientists research treatments for various diseases. That’s why the government can count on them in times of crisis.  

On March 24-25, I tuned in for a virtual summit hosted by the Biotechnology Innovation Organization, where industry leaders and senior government officials discussed the many ways they’re already working together to fast-track a cure. Participants also brainstormed other ways they might be able to cooperate.  

 
Sign Up for Our Email Newsletter

RECENT NEWS

It's time to kill the patient COVID-19 tax

It's time to kill the patient COVID-19 tax

With a pandemic ravaging the nation, now isn’t the time to hurt patients’ ability to access critical medicines....  Read more

Why Russia became the 'sudden' coronavirus epicenter in Europe

Why Russia became the 'sudden' coronavirus epicenter in Europe

And after a relatively few cases were documented in March, Russia now has the second-fastest rate of new infections world...  Read more

Former FDA Associate Commissioner Peter Pitts says we should be ‘cautiously optimistic’ about the early positive results from Moderna vaccine

Former FDA Associate Commissioner Peter Pitts says we should be ‘cautiously optimistic’ about the early positive results from Moderna vaccine

Peter Pitts appears on KTLA 5 to discuss COVID-19 and the Moderna vaccine...  Read more

DRUGWONKS BLOG